BRPI0804623A2 - uso de albumina humana terapêutica para a preparação de um fármaco para o tratamento de pacientes sofrendo de distúrbios cognitivos - Google Patents
uso de albumina humana terapêutica para a preparação de um fármaco para o tratamento de pacientes sofrendo de distúrbios cognitivosInfo
- Publication number
- BRPI0804623A2 BRPI0804623A2 BRPI0804623-9A BRPI0804623A BRPI0804623A2 BR PI0804623 A2 BRPI0804623 A2 BR PI0804623A2 BR PI0804623 A BRPI0804623 A BR PI0804623A BR PI0804623 A2 BRPI0804623 A2 BR PI0804623A2
- Authority
- BR
- Brazil
- Prior art keywords
- drug
- preparation
- treatment
- patients suffering
- human albumin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
USO DE ALBUMINA HUMANA TERAPêUTICA PARA A PREPARAçãO DE UM FáRMACO PARA O TRATAMENTO DE PACIENTES SOFRENDO DE DISTúRBIOS COGNITIVOS. A presente invenção refere-se ao uso de albumina humana terapêutica para a preparação de um fármaco para o tratamento de pacientes sofrendo de distúrbios cognitivos. A invenção é baseada no uso de albumina humana terapêutica para a preparação de um fármaco para o tratamento de pacientes sofrendo de distúrbios cognitivos, em que o modelo de administração do fármaco inclui a administração ao paciente por um mínimo de três vezes sucessivas, de uma quantidade terapeuticamente eficiente de albumina terapêutica humana por meio de troca de plasma e/ou de perfusão intravenosa, independente do conteúdo de A<225> no sangue do paciente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200702831A ES2332846B1 (es) | 2007-10-26 | 2007-10-26 | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
ES200702831 | 2007-10-26 |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0804623A2 true BRPI0804623A2 (pt) | 2009-06-30 |
BRPI0804623B1 BRPI0804623B1 (pt) | 2020-02-11 |
BRPI0804623B8 BRPI0804623B8 (pt) | 2021-05-25 |
Family
ID=40583637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0804623A BRPI0804623B8 (pt) | 2007-10-26 | 2008-10-23 | uso de albumina humana terapêutica para a preparação de um fármaco para o tratamento de pacientes sofrendo de distúrbios cognitivos |
Country Status (17)
Country | Link |
---|---|
US (1) | US7851446B2 (pt) |
EP (1) | EP2111868B1 (pt) |
JP (1) | JP5437619B2 (pt) |
CN (1) | CN101417123B (pt) |
AR (1) | AR068901A1 (pt) |
AU (1) | AU2008233025B8 (pt) |
BR (1) | BRPI0804623B8 (pt) |
CA (1) | CA2641830C (pt) |
CL (1) | CL2008003133A1 (pt) |
ES (2) | ES2332846B1 (pt) |
HK (1) | HK1126689A1 (pt) |
MX (1) | MX2008013635A (pt) |
NZ (1) | NZ572131A (pt) |
PL (1) | PL2111868T3 (pt) |
PT (1) | PT2111868E (pt) |
RU (1) | RU2414925C2 (pt) |
UY (1) | UY31418A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10112000B2 (en) | 2010-07-08 | 2018-10-30 | Asahi Kasei Medical Co., Ltd. | Method for reducing amyloid beta concentration in blood |
US10525107B2 (en) | 2016-08-18 | 2020-01-07 | Alkahest, Inc. | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
EP3484502B1 (en) * | 2016-08-18 | 2021-08-25 | Alkahest, Inc. | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
US11040068B2 (en) | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
BR112019022402A2 (pt) * | 2017-04-26 | 2020-05-19 | Alkahest Inc | regime de dosagem para tratamento de comprometimentos cognitivo e motor com plasma sanguíneo e produtos de plasma sanguíneo |
AU2019306477A1 (en) * | 2018-07-20 | 2021-02-11 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
EP3643319A1 (en) * | 2018-10-25 | 2020-04-29 | Grifols Worldwide Operations Limited | Use of low volume plasma exchange for the treatment of alzheimer's disease in early and middle stages |
CN113056275A (zh) | 2018-10-26 | 2021-06-29 | 万能溶剂有限公司 | 血浆和血浆组分用于改善疼痛、伤口愈合和术后恢复的用途 |
CA3215030A1 (en) * | 2021-04-30 | 2022-11-03 | Victor Grifols Roura | Use of therapeutic plasma exchange and low volume plasma exchange for the treatment of a cognitive impairment |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3612137A1 (de) | 1986-04-10 | 1987-10-15 | Biotest Pharma Gmbh | Steriles plasmaaustauschmittel |
US5112298A (en) | 1990-06-25 | 1992-05-12 | Baxter International Inc. | Apheresis method and device |
US5178603A (en) | 1990-07-24 | 1993-01-12 | Baxter International, Inc. | Blood extraction and reinfusion flow control system and method |
US6627151B1 (en) * | 1997-06-13 | 2003-09-30 | Helmut Borberg | Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion |
JP4851676B2 (ja) | 2000-05-23 | 2012-01-11 | ザ ユニバーシティ オブ サザン カリフォルニア | アルツハイマー病におけるldlレセプタータンパク質1(lrp−1)の役割 |
EP1370240A4 (en) * | 2001-03-02 | 2004-09-22 | Neuron Therapeutics Inc | NEUROPROTECTOR FORMULATIONS AND METHOD |
US20050227941A1 (en) | 2001-12-17 | 2005-10-13 | Karen Duff | Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases |
US7692011B2 (en) | 2002-10-04 | 2010-04-06 | Prana Biotechnology Limited | 8-hydroxy and 8-mercapto quinazolinones |
WO2004056318A2 (en) * | 2002-12-19 | 2004-07-08 | New York University | Method for treating amyloid disease |
DK1592439T3 (da) | 2003-02-13 | 2007-09-10 | Octapharma Ag | Fremgangsmåde til fremstilling af en albuminoplösning |
JP2007528857A (ja) | 2003-07-11 | 2007-10-18 | ミリアド ジェネティクス, インコーポレイテッド | アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態 |
AT413336B (de) * | 2003-09-12 | 2006-02-15 | Mattner Frank Dr | Apherese-vorrichtung |
US20050182044A1 (en) | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
US7436304B1 (en) | 2005-07-19 | 2008-10-14 | Visible Assets, Inc | Evidence tracking |
-
2007
- 2007-10-26 ES ES200702831A patent/ES2332846B1/es not_active Expired - Fee Related
-
2008
- 2008-10-17 AR ARP080104523A patent/AR068901A1/es unknown
- 2008-10-17 NZ NZ572131A patent/NZ572131A/en unknown
- 2008-10-17 RU RU2008141076/15A patent/RU2414925C2/ru active
- 2008-10-22 PT PT83803015T patent/PT2111868E/pt unknown
- 2008-10-22 ES ES08380301T patent/ES2428698T3/es active Active
- 2008-10-22 PL PL08380301T patent/PL2111868T3/pl unknown
- 2008-10-22 EP EP08380301.5A patent/EP2111868B1/en active Active
- 2008-10-23 UY UY31418A patent/UY31418A1/es not_active Application Discontinuation
- 2008-10-23 BR BRPI0804623A patent/BRPI0804623B8/pt active IP Right Grant
- 2008-10-23 CN CN2008101705786A patent/CN101417123B/zh active Active
- 2008-10-23 MX MX2008013635A patent/MX2008013635A/es active IP Right Grant
- 2008-10-23 CL CL2008003133A patent/CL2008003133A1/es unknown
- 2008-10-24 US US12/257,814 patent/US7851446B2/en active Active
- 2008-10-24 CA CA2641830A patent/CA2641830C/en active Active
- 2008-10-24 AU AU2008233025A patent/AU2008233025B8/en active Active
- 2008-10-24 JP JP2008274076A patent/JP5437619B2/ja active Active
-
2009
- 2009-07-02 HK HK09105923.2A patent/HK1126689A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN101417123B (zh) | 2012-06-27 |
JP5437619B2 (ja) | 2014-03-12 |
CA2641830C (en) | 2013-07-16 |
JP2009108059A (ja) | 2009-05-21 |
US20090111740A1 (en) | 2009-04-30 |
CN101417123A (zh) | 2009-04-29 |
ES2332846A1 (es) | 2010-02-12 |
PL2111868T3 (pl) | 2014-01-31 |
ES2332846B1 (es) | 2010-07-08 |
BRPI0804623B8 (pt) | 2021-05-25 |
BRPI0804623B1 (pt) | 2020-02-11 |
NZ572131A (en) | 2010-06-25 |
MX2008013635A (es) | 2009-05-11 |
ES2428698T3 (es) | 2013-11-08 |
AU2008233025B2 (en) | 2013-06-27 |
RU2414925C2 (ru) | 2011-03-27 |
CA2641830A1 (en) | 2009-04-26 |
PT2111868E (pt) | 2013-10-17 |
UY31418A1 (es) | 2009-05-29 |
EP2111868A1 (en) | 2009-10-28 |
CL2008003133A1 (es) | 2009-08-07 |
AU2008233025A1 (en) | 2009-05-14 |
AU2008233025B8 (en) | 2013-07-25 |
RU2008141076A (ru) | 2010-04-27 |
US7851446B2 (en) | 2010-12-14 |
HK1126689A1 (en) | 2009-09-11 |
EP2111868B1 (en) | 2013-08-21 |
AR068901A1 (es) | 2009-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0804623A2 (pt) | uso de albumina humana terapêutica para a preparação de um fármaco para o tratamento de pacientes sofrendo de distúrbios cognitivos | |
American Society of Anesthesiologists Task Force on Chronic Pain Management | Practice guidelines for chronic pain management: an updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine | |
JP2022009125A5 (pt) | ||
NZ597378A (en) | Treatment of multiple sclerosis with laquinimod | |
BRPI0820800A2 (pt) | Dispositivo médico implantável para liberação controlada de droga, e, métodos para administração de uma droga na bexiga de um paciente e para tratar a bexiga em um paciente | |
EP2216024A3 (en) | Use of Ranolazine for the treatment of cardiovascular diseases | |
BR112012011575A2 (pt) | sistema integrado e extensível de anestesia | |
WO2007109006A3 (en) | Infusion device capable of providing multiple liquid medicaments | |
WO2008022189A3 (en) | Administration of high potency platinum compound formulations by inhalation | |
EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
BRPI0806392A8 (pt) | uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica | |
EP1849462A3 (en) | A method of alleviating signs and symptons of Spasticity | |
Chen et al. | Efficacy and safety of dexmedetomidine versus propofol for the sedation of tube-retention after oral maxillofacial surgery | |
JP2010518164A5 (pt) | ||
CY1115269T1 (el) | Χρηση ανταγωνιστων οπιοειδων για την παρασκευη ενος φαρμακου στη θεραπευτικη αγωγη εκφυλιστικων ασθενειων του αμφιβληστροειδους | |
AU2016208779B2 (en) | Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function | |
BR112014004339A2 (pt) | suspensão oral | |
Fyneface-Ogan et al. | Anaesthetic management of a super morbidly obese patient for total abdominal hysterectomy: a few more lessons to learn | |
Cangemi Jr | Administration of general anesthesia for outpatient orthognathic surgical procedures | |
RU2006101061A (ru) | Азенапин для лечения шизофрении у пациентов с избыточной массой тела или предрасположенностью к избыточной массе тела | |
Usichenko et al. | Auricular acupuncture | |
Ohshita et al. | Anesthetic management of a patient with multiple sclerosis | |
NZ599227A (en) | Therapeutic agent for chronic pain | |
JP2010519274A5 (pt) | ||
Winter et al. | 0561 Solriamfetol Real World Experience Study: Safety, Efficacy, and Follow-Up for Patients with Obstructive Sleep Apnea in Germany |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B25G | Requested change of headquarter approved |
Owner name: GRIFOLS, S.A. (ES) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/02/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/10/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |